Relapse and Acquired Rifampin Resistance in HIV-Infected Patients with Tuberculosis Treated with Rifampin- or Rifabutin-Based Regimens in New York City, 1997–2000

Background. The relationship between rifamycin use and either relapse or treatment failure with acquired rifampin resistance (ARR) among human immunodeficiency virus (HIV)–infected patients with tuberculosis (TB) is not well understood. Methods. We conducted a retrospective cohort study of HIV-infec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2005-07, Vol.41 (1), p.83-91
Hauptverfasser:	Li, Jiehui, Munsiff, Sonal S., Driver, Cynthia R., Sackoff, Judith
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult AIDS AIDS-Related Opportunistic Infections - drug therapy AIDS-Related Opportunistic Infections - microbiology Antibiotics Antibiotics, Antitubercular - administration & dosage Antibiotics, Antitubercular - pharmacology Antibiotics, Antitubercular - therapeutic use Clinical outcomes Cohort Studies Drug dosages Drug Resistance, Bacterial Female Hematocrit HIV HIV Infections - complications HIV/AIDS Human immunodeficiency virus Humans Lungs Male Medical treatment Medical treatment failures Mycobacterium tuberculosis Mycobacterium tuberculosis - drug effects New York City Pulmonary tuberculosis Recurrence Relapse Retrospective Studies Rifabutin - administration & dosage Rifabutin - therapeutic use Rifampin - administration & dosage Rifampin - pharmacology Rifampin - therapeutic use Rifamycins T lymphocytes Treatment Failure Tuberculosis Tuberculosis - drug therapy Tuberculosis - microbiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!